[Management for treatment-induced adverse reaction--chemotherapy].
Department of Molecular-Targeting Therapy for Breast Cancer, Innovation Center for Translational Research, Kumamoto University Hospital.
Yutaka
Y
Yamamoto
Hirotaka
H
Iwase
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D060831:Hand-Foot Syndrome / Q000188:drug therapy; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000188:drug therapy; D013280:Stomatitis / Q000139:chemically induced / Q000628:therapy; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000970:Antineoplastic Agents